StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KAHAN.BO$42.00+0.00%
Fair $42.00+0.0%

KAHAN.BO

Kahan Packaging Limited

Consumer Cyclical / Packaging & ContainersBSE

$42.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $42.00Fund rank 24/100 · Data gapFallback financials|
SA 45/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-11.0M · quality 51.3/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 24/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · KAHAN.BOLocal privado en este navegador · Kahan Packaging Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$114M

P/E

9.9x

↓

EV/EBITDA

7.0x

↓

ROE

11.4%

↑

Gross Margin

22.0%

↓

Debt/Equity

0.81

↑
52-Week Range$42
$38$71

TradingView lightweight chart

KAHAN.BO price, volumen y niveles de valoración

Último $42.00Periodo -73.7%
Fair value: $42.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+21.4%

FCF CAGR

—

FCF margin

-3.9%

FCF / Net income

-0.98x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $283.9M · net income $11.2M · FCF $-11.0M

2022-FY → 2025-FY

Gross margin

22.0%+2.0% pts

Operating margin

7.8%+3.2% pts

Net margin

3.9%+2.7% pts

FCF margin

-3.9%+4.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$283.9M$283.9M$247.0M$206.7M$158.8M
Net Income$11.2M$11.2M$10.0M$10.0M$2.0M
EBITDA$27.7M$27.7M$23.7M$20.2M$8.5M
EPS4.124.124.593.690.73
Gross Margin22.0%22.0%19.8%22.0%19.9%
Operating Margin7.8%7.8%8.2%8.9%4.6%
Net Margin3.9%3.9%4.1%4.9%1.2%
Balance Sheet
Debt/Equity0.810.810.733.538.87
Current Ratio1.151.15———
Cash Flow
Free Cash Flow$-11.0M$-11.0M$-30.3M$-7.1M$-12.6M
Returns
ROE11.4%11.4%11.5%45.8%28.4%
Valuation
P/E9.919.9118.30——
EV/EBITDA6.996.9910.27——
P/B1.161.162.10——
Growth & Yield
Revenue Growth14.9%14.9%19.5%30.2%—
EPS Growth-10.2%-10.2%24.3%407.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-3.3%

fácil

EPS terminal req.

$3.73

Spread vs growth

-7.0%

5Y implied EPS CAGR

1.8%

fácil

EPS terminal req.

$4.51

Spread vs growth

-12.1%

10Y implied EPS CAGR

5.8%

razonable

EPS terminal req.

$7.26

Spread vs growth

-16.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.8%

Total return

-40.8%

Start / end P/E

15.5x → 10.2x

EPS bridge

4.59 → 4.12

Residual

+3.5%

EPS growth-10.2%
Multiple rerating-34.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term+3.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.